Clinical Trial Update: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly ixabepilone with or without biweekly bevacizumab in epithelial ovarian cancer and related peritoneal cancers; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Ixempra (ixabepilone)

Snippet

Sponsor: Yale University | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14